Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Newborn screening of inherited metabolic disease in Korea

유전성 대사질환의 신생아 스크리닝

  • Lee, Dong Hwan (Department of Pediatrics, College of Medicine, Soonchunhyang University)
  • 이동환 (순천향대학교 의과대학 소아과학교실)
  • Received : 2006.10.10
  • Accepted : 2006.10.30
  • Published : 2006.11.15
Download PDF
⟨ Previous Next ⟩

Abstract

In 1991, the Ministry of Health & Social affairs adopted a nationwide service program for neonatal screening of phenylketonuria, galactosemia, maple syrup urine disease, homocystinuria, histidinemia & congenital hypothyroidism for newborns delivered from low class pregnant women registered in health centers. Government decreased the test items from six to two, PKU & congenital hypothyroidism to increase test numbers with same budget from 1995. Government decided to test PKU & hypothyroidism for all newborns from 1997. 78 laboratories wanted to participate for neonatal screening test in 1999. Government didn't decide laboratory center for a certain district and placed responsibility on free competition. Government are planning to test 573,000 newborns from 1998, Government decided to screen 6 items PKU, congenital hypothyroidism, maple syrup urine disese, homocystinuria, galactosemia and congenital adrenal hyperplasia from 2006. 17 laboratores are participating now. The cost of screening test is supported by both the federal government and local government on a 40-60 basis. In case a patient with an inherited metabolic disease is diagnosed by screening of government program, special milk is provided at government's expense. Interlaboratory quality control was started 6 times a year from 1994. According to the government project, 3,707,773 newborns were screened. 86 PKU, 718 congenital hypothyroidism were detected. So incidence of PKU is 1/43,114 and congenital hypothyroidism is 1/4,612. Maeil dairy company produced new special formula for PKU, MMA and PA, MSUD, urea cycle disorder, homocystinuria, isovaleric acidemia from Oct. 1999. The cost benefit of performing screening procedures coupled with treatment has been estimated to be as high as 1.77 times in PKU, 11.11 times in congenital hypothyroidism than cost without screening. We are trying to increase the budget to test all newborns for Tandem mass sereening & Wilson disease from 2008. Now it is a very important problem to decrease laboratory numbers of neonatal screening in Korea. So we are considering 4-5 central laboratories which cover all newborns and are equipped with tandem mass spectrometer & enzyme immunoassay for TSH, 17OHP & enzyme colorimetric assay for galactose.

Keywords

References

  1. Bickel H, Guthrie R, Hammersen G. Neonatal screening for inborn error of metabolism. Springer-Verlag, 1980;1-79
  2. Lee DH. Neonatal screening in Korea, In: New trends in neonatal screening. Hokkaido Univ. press, 1994;3-5
  3. Lee DH. Neonatal screening test. J of the Kor Medical Association 1994;37:1464-80
  4. Lee HJ, Moon HR, Shin YS. Clinical approach of inherited metabolic disease. Orombo 1990;152-7
  5. Lee DH, Jang KA, Lee SJ, Yoo H. The Incidence of inborn error of metabolism and hypothyroidism in Korean newborns. The J of Soonchunhyang University 1988;11:201-9
  6. Lee DH. Neonatal screening for inborn errors of metabolism. J of Kor Pediatr Association 1987;30:9-16
  7. Moon DS, Kim DW, Lee DH, Lee SJ, You KS, Moon HR, et al. Cost-Benefit analysis of newborn mass screening for phenylketonuria and congenital hypothyroidism in Korea. J. of Soonchunhyang Medical College 1: 459-470, 1995
  8. Yoon HC, Kim NC, Lee DH. A cost-Benefit analysis on neonatal screening of phenylketonuria and congenital hypothyroidism in Korea. Korean J Pediatr 2005;48:369-75
  9. Schoen EJ, Baker JC, Colby CJ, To TT. Cost-benefit analysis of universal tandem mass spectrometry for newborn screening. Pediatrics 2002;110:781-6 https://doi.org/10.1542/peds.110.4.781
  10. Ryoo HO, Lee DH. Cost-benefit analysis of universal tandem mass spectrometry for newborn screening in Korea. Program and abstracts 56th annual fall meeting of the Korean Pediatrics Society, 2005:77
  11. Park KH, Lee YK, Choi TY, Kim WB, LeeDH. Seven cases of ornithine transcarbamylase deficiency. Kor J of Clinical Pathology 1999;19:308-14
  12. Cheon KS, Lee DH. Isovaleric Acidemia in Siblings Diagnosed by Organic Acid Analysis. J of the Kor Pediatr Society 2000;43:828-31
  13. Yoon HR, Lee KR, Kang SW, Lee DW, Yoo HW, Min WK, et al. Screening of newborns and high-risk group of children for inbom metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clinica Chimica Acta 2005;354:167-80 https://doi.org/10.1016/j.cccn.2004.11.032
  14. Kim SH, Suh ES, Lee DH. EEG in Phenylketonuria. J of the Kor Pediatr Society 40:759-766, 1997
  15. Hong HS, Kim DH, Lee HK, Kwon KH, Choi DL, Lee DH. MR Imaging of Phenylketonuria. J of the Kor Radiol Soc 1997;37:541-5 https://doi.org/10.3348/jkrs.1997.37.3.541
  16. Hong HK, Lee WR, Lee DH. A Case of Maternal Phenyketonuria. The Kor J of Perinatol 1999;10:387-90
  17. Nam HG, Shim JS, Lee DH, and Lee SJ. A Clinical Study in Phenylketonuria. J of Kor Pediatr Association 1992;35:69-79
  18. Chong CH, Lee HY, Lee DH, Lee SJ, Cha KW, Yim JB,et al. Pterin and DHPR Measurement and DNA Analysis in Korean PKU Patients. J of Kor Pediatr Society 1993;36:1681-90
  19. Lee DH. Recent Advances in Treatment of Inherited Metabolic Diseases. The J of the Kor Medical Association 1988;31:1267-73
  20. Lee DH. Clinical Experience in Dietary Management of Phenylketonuria with Maeil PKU-1, PKU-2 Formula. J Korean Soc of Inherited Metabolic Disease 2002;2:89-94
  21. Park IS, Cho HJ, Lee DH and Song SH. Galactosemia Detected by Neonatal Screening Test. J Korean Pediatr Soc 2003;46:440-6
  22. Kenneth AP. US Newborn Screening System Guildlines II:Follow-ip of Children, Diagnosis, Management, and Evaluation, The Journal of Pediatrics 2000;137:S1-S46 https://doi.org/10.1067/mpd.2000.109437
  23. Choi TY, Kim WB, Kang DY, Lee DH. A Case of Homocystinuria. Kor. J. of Clinical Pathology 13:351-6, 1993
  24. Choi TY, Kim JW, Min WK, Lee DH, et al. Analysis of Blood Sample Records for Neonatal Screening Test and External Quality Assessment for Inborn Errors of Metabolism in Korea. J Korean Soc of Maternal and CHild Health 2003;7:7-17
  25. Hahn SH, Lee DH. Pilot study of mass screening for Wilson's disease in Korea. Molecular Genetics and Metabolism 2002;76:133-6 https://doi.org/10.1016/S1096-7192(02)00026-4
  26. Hahn YJ, Lee DH, Kim ES. Plans to improve the mass screening tests on inborn errors of metabolism in Korea. Korean public health and society reserch center in 송 department of ministry of health and wellfare in Korea, 2000:51-68